Short Wave COVID-19 boosters are here
Oct 19, 2021
Rob Stein, NPR health correspondent, dives into the ongoing rollout of COVID-19 vaccine boosters. He discusses the FDA's expected authorization of boosters for Moderna and Johnson & Johnson, raising ethical concerns about prioritizing U.S. boosters over global vaccine needs. The conversation also covers the complexities of vaccinating the unvaccinated, upcoming options for children aged 5 to 11, and how booster shots could enhance immunity amidst rising variants. Preparing for a return to normalcy remains a key focus as safety measures persist.
AI Snips
Chapters
Transcript
Episode notes
Booster Debate
- Booster rollout sparked debate about scientific need and ethical considerations.
- Critics argue boosters divert resources from vaccinating the unvaccinated globally.
Booster Recommendations
- Moderna recipients should get a Moderna booster after eight months.
- J&J recipients should get a Pfizer or Moderna booster after two months.
Mixing and Matching Boosters
- If you received J&J initially, strongly consider a Pfizer or Moderna booster for better protection.
- If you received Pfizer or Moderna, either is fine for your booster.